INGN Q1 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena

INGNInogen, Inc.

$171M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$78M+8.1% YoY

Gross Profit

$34M44.1% margin

Operating Income

-$16M-20.9% margin

Net Income

-$15M-18.7% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+2.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$316M

Total Liabilities

$124M

Stockholders' Equity

$192M

Cash & Equivalents

$107M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$72M	+8.1%
Gross Profit	$34M	$31M	+11.8%
Operating Income	-$16M	-$22M	+25.7%
Net Income	-$15M	-$20M	+28.4%

Geographic Segments

UNITED STATES

$52M67%

Non-US

$26M33%